INS and coronary artery disorder: Similarly, patients who used both insulin and OAD (10.9%, 95% CI 7.5 ~ 14.3%) had higher 10-year risk of fatal (P = 0.002) CHD, compared to those under OAD monotherapy (6.4%, 95% CI 5.6 ~ 7.1%).